Cefepime Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Cefepime Hydrochloride Injection (injection) from Baxter Healthcare with status To Be Discontinued. The shortage was first posted on Oct 30, 2026.
Shortage details
- Status
- To Be Discontinued
- Company
- Baxter Healthcare
- Package NDC
- 0338-1301-48
- Dosage Form
- Injection
- Presentation
- Cefepime Hydrochloride in Plastic Container, Injection, 2g/100mL (NDC 0338-1301-48)
- Initial Posting
- Oct 30, 2026